Business Context and Reporting Period
This Form 8-K was filed by Bio-Rad Laboratories, Inc. on October 7, 2008. The report details a corporate governance event regarding the transfer of the company's stock listing rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a listing transfer and does not contain financial statement data.
Material Changes
The primary material change reported is the Company's intention to transfer the listing of its common stock (Class A and Class B) from the NYSE Alternext (formerly the American Stock Exchange or AMEX) to the NYSE Big Board.
Outlook and Management Commentary
- Implementation Timeline: The Company anticipates that its common stock will begin trading on the NYSE Big Board on or about October 24, 2008.
- Notification: The Company has formally notified the NYSE Alternext of its intention to transfer the listing.
- Exhibits: A press release dated October 7, 2008, is included as Exhibit 99.1.
Investor Verification Checklist
- Confirm the effective date of the stock trading transfer to the NYSE Big Board (anticipated October 24, 2008).
- Verify the ticker symbol changes or trading procedures associated with the move from NYSE Alternext to the NYSE Big Board.
- Review the attached press release (Exhibit 99.1) for any additional details on the rationale for the transfer.